Germline polymorphisms at JAK2 and TERT endow individuals with a predisposition to developing a MPN, which emerged from all the four main studies interrogating large patient and control data sets by a genome-wide association approach [10,11,12,13]. The gene discussed is TERT; the disease is myeloproliferative neoplasm.